COSMOS Pharmaceutical Corporation (3349) Stock Statistics & Valuation Metrics

COSMOS Pharmaceutical Corporation has a market cap or net worth of ¥496.38B. The enterprise value is ¥493.59B.

COSMOS Pharmaceutical Corporation has 80,001,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

COSMOS Pharmaceutical Corporation’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 8.37%.

The current PE Ratio of COSMOS Pharmaceutical Corporation is 15.2. COSMOS Pharmaceutical Corporation’s PEG ratio is 4.18.

In the last 12 months, COSMOS Pharmaceutical Corporation had revenue of 1.10T and earned 32.05B in profits. Earnings per share was 404.33.

In the last 12 months, operating cash flow was 58.79B and capital expenditures -70.46B, giving a free cash flow of -11.67B billion.

COSMOS Pharmaceutical Corporation pays an annual dividend of ¥42, resulting in a dividend yield of 1.28%

COSMOS Pharmaceutical Corporation upcoming earnings date is Oct 14, 2026, TBA (Confirmed).

COSMOS Pharmaceutical Corporation as a current ratio of 0.77, with Debt / Equity ratio of 27.66%

In the past 12 months, COSMOS Pharmaceutical Corporation has paid 12.17B in taxes.

COSMOS Pharmaceutical Corporation EV to EBITDA ratio is 7.16, with an EV/FCF ratio of -41.05.

COSMOS Pharmaceutical Corporation has ¥61.34B in cash and marketable securities with ¥78.48B in debt, giving a net cash position of -¥17.14B billion.

Gross margin is 20.89%, with operating margin of 3.85%, and net profit margin of 2.91%.

The average price target for COSMOS Pharmaceutical Corporation is ¥7,300.00, which is 11.43% higher than the current price. The consensus rating is Hold